4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-22-023149
Options or other derivatives
- Director acquired 55,090 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bjork Elisabeth · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2022-06-13 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +47,745 | $10.77 | 2032-06-13 | 47,745 | 47,745 | D | ||
| 2022-06-13 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +7,345 | $6.80 | $49,946 | $10.77 | 2032-06-13 | 7,345 | 7,345 | D |
Loading xslF345X03/form4.xml…